Book contents
- Movement Disorders and Inherited Metabolic Disorders
- Movement Disorders and Inherited Metabolic Disorders
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Acknowledgments
- Section I General Principles and a Phenomenology-Based Approach to Movement Disorders and Inherited Metabolic Disorders
- Chapter 1 Treatable Metabolic Movement Disorders: The Top 10
- Chapter 2 The Importance of Movement Disorders in Inborn Errors of Metabolism
- Chapter 3 The Importance of Inborn Errors of Metabolism for Movement Disorders
- Chapter 4 Imaging in Metabolic Movement Disorders
- Chapter 5 Biochemical Testing for Metabolic Movement Disorders
- Chapter 6 Genetic Testing for Metabolic Movement Disorders
- Chapter 7 A Phenomenology-Based Approach to Inborn Errors of Metabolism with Ataxia
- Chapter 8 A Phenomenology-Based Approach to Inborn Errors of Metabolism with Dystonia
- Chapter 9 A Phenomenology-Based Approach to Inborn Errors of Metabolism with Parkinsonism
- Chapter 10 A Phenomenology-Based Approach to Inborn Errors of Metabolism with Spasticity
- Chapter 11 A Phenomenology-Based Approach to Inborn Errors of Metabolism with Myoclonus
- Section II A Metabolism-Based Approach to Movement Disorders and Inherited Metabolic Disorders
- Section III Conclusions and Future Directions
- Appendix: Video Captions
- Index
- References
Chapter 11 - A Phenomenology-Based Approach to Inborn Errors of Metabolism with Myoclonus
from Section I - General Principles and a Phenomenology-Based Approach to Movement Disorders and Inherited Metabolic Disorders
Published online by Cambridge University Press: 24 September 2020
Book contents
- Movement Disorders and Inherited Metabolic Disorders
- Movement Disorders and Inherited Metabolic Disorders
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Acknowledgments
- Section I General Principles and a Phenomenology-Based Approach to Movement Disorders and Inherited Metabolic Disorders
- Chapter 1 Treatable Metabolic Movement Disorders: The Top 10
- Chapter 2 The Importance of Movement Disorders in Inborn Errors of Metabolism
- Chapter 3 The Importance of Inborn Errors of Metabolism for Movement Disorders
- Chapter 4 Imaging in Metabolic Movement Disorders
- Chapter 5 Biochemical Testing for Metabolic Movement Disorders
- Chapter 6 Genetic Testing for Metabolic Movement Disorders
- Chapter 7 A Phenomenology-Based Approach to Inborn Errors of Metabolism with Ataxia
- Chapter 8 A Phenomenology-Based Approach to Inborn Errors of Metabolism with Dystonia
- Chapter 9 A Phenomenology-Based Approach to Inborn Errors of Metabolism with Parkinsonism
- Chapter 10 A Phenomenology-Based Approach to Inborn Errors of Metabolism with Spasticity
- Chapter 11 A Phenomenology-Based Approach to Inborn Errors of Metabolism with Myoclonus
- Section II A Metabolism-Based Approach to Movement Disorders and Inherited Metabolic Disorders
- Section III Conclusions and Future Directions
- Appendix: Video Captions
- Index
- References
Summary
Myoclonus is a hyperkinetic movement disorder defined as a sudden, brief, involuntary jerk of a muscle or a muscle group. Myoclonus can be caused by muscle contraction (positive myoclonus) or by loss of muscle contraction (negative myoclonus). The prevalence of myoclonus is largely unknown. Symptoms are not always severe enough to attract medical attention and signs of myoclonus can be hard to recognize.
- Type
- Chapter
- Information
- Movement Disorders and Inherited Metabolic DisordersRecognition, Understanding, Improving Outcomes, pp. 155 - 170Publisher: Cambridge University PressPrint publication year: 2020
References
Caviness, JN, Alving, LI, Maraganore, DM, et al. The incidence and prevalence of myoclonus in Olmsted County, Minnesota. Mayo Clin Proc. 1999;74(6):565–9.Google Scholar
Gouider-Khouja, N, Kraoua, I, Benrhouma, H, Fraj, N, Rouissi, A. Movement disorders in neuro-metabolic diseases. Eur J Paediatr Neurol. 2010;14(4):304–7.CrossRefGoogle ScholarPubMed
Zutt, R, van Egmond, ME, Elting, JW, et al. A novel diagnostic approach to patients with myoclonus. Nat Rev Neurol. 2015;11(12):687–97.CrossRefGoogle ScholarPubMed
Apartis, E, Vercueil, L. To jerk or not to jerk: A clinical pathophysiology of myoclonus. Rev Neurol (Paris). 2016; 172 (8–9): 465–76.CrossRefGoogle ScholarPubMed
van der Veen, S, Zutt, R, Elting, JWJ, et al. Progressive myoclonus ataxia: Time for a new definition? Mov Disord. 2018;33(8):1281–6.CrossRefGoogle ScholarPubMed
Caviness, JN. Treatment of myoclonus. Neurotherapeutics. 2014;11(1):188–200.CrossRefGoogle ScholarPubMed
Koens, LH, Kuiper, A, Coenen, MA, et al. Ataxia, dystonia and myoclonus in adult patients with Niemann–Pick type C. Orphanet J Rare Dis. 2016;11:121.CrossRefGoogle ScholarPubMed
Ritz, K, Gerrits, MC, Foncke, EM, et al. Myoclonus-dystonia: Clinical and genetic evaluation of a large cohort. J Neurol Neurosurg Psychiatry. 2009;80(6):653–8.CrossRefGoogle ScholarPubMed
Dreissen, YE, Tijssen, MA. The startle syndromes: Physiology and treatment. Epilepsia. 2012;53 Suppl 7:3–11.Google Scholar
Neveling, K, Feenstra, I, Gilissen, C, et al. A post-hoc comparison of the utility of Sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Hum Mutat. 2013;34(12):1721–6.CrossRefGoogle ScholarPubMed
van Egmond, ME, Lugtenberg, CHA, Brouwer, OF, et al. A post hoc study on gene panel analysis for the diagnosis of dystonia. Mov Disord. 2017;32(4):569–75.CrossRefGoogle Scholar
Coutelier, M, Goizet, C, Durr, A, et al. Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia. Brain. 2015;138(Pt 8):2191–205.CrossRefGoogle ScholarPubMed
Campistol, J. Epilepsy in inborn errors of metabolism with therapeutic options. Semin Pediatr Neurol. 2016;23(4):321–31.CrossRefGoogle ScholarPubMed
Malek, N, Stewart, W, Greene, J. The progressive myoclonic epilepsies. Pract Neurol. 2015;15(3):164–71.CrossRefGoogle ScholarPubMed
Sedel, F, Gourfinkel-An, I, Lyon-Caen, O, et al. Epilepsy and inborn errors of metabolism in adults: A diagnostic approach. J Inherit Metab Dis. 2007;30(6):846–54.Google Scholar
Beal, JC, Cherian, K, Moshe, SL. Early-onset epileptic encephalopathies: Ohtahara syndrome and early myoclonic encephalopathy. Pediatr Neurol. 2012;47(5):317–23.CrossRefGoogle ScholarPubMed
Koens, LH, Tijssen, MAJ, Lange, F, et al. Eye movement disorders and neurological symptoms in late-onset inborn errors of metabolism. Mov Disord. 2018;33(12):1844–56.CrossRefGoogle ScholarPubMed
Hollak, CEM, Lachman, R. Inherited Metabolic Disease in Adults: A Clinical Guide. New York, NY: Oxford University Press; 2016.Google Scholar
Sedel, F, Lyon-Caen, O, Saudubray, JM. Therapy insight: Inborn errors of metabolism in adult neurology. A clinical approach focused on treatable diseases. Nat Clin Pract Neurol. 2007;3(5):279–90.Google Scholar
Poll-The, BT, de Buy, Maillette Wenniger-Prick, LJ. The eye in metabolic diseases: Clues to diagnosis. Eur J Paediatr Neurol. 2011;15(3):197–204.CrossRefGoogle ScholarPubMed
Poll-The, BT, de Buy, Maillette Wenniger-Prick, LJ, Barth, PG, Duran, M. The eye as a window to inborn errors of metabolism. J Inherit Metab Dis. 2003; 26 (2–3): 229–44.CrossRefGoogle ScholarPubMed
Schultz, M L, Tecedor, L, Chang, M, Davidson, BL. Clarifying lysosomal storage diseases. Trends Neurosci. 2011;34(8):401–10.CrossRefGoogle ScholarPubMed
Accardo, A, Pensiero, S, Ciana, G, Parentin, F, Bembi, B. Eye movement impairment recovery in a Gaucher patient treated with miglustat. Neurol Res Int. 2010;2010:358534.Google Scholar
Park, JK, Orvisky, E, Tayebi, N, et al. Myoclonic epilepsy in Gaucher disease: Genotype–phenotype insights from a rare patient subgroup. Pediatr Res. 2003;53(3):387–95.Google Scholar
Stelten, BML, van de Warrenburg, BPC, Wevers, RA, Verrips, A. Movement disorders in cerebrotendinous xanthomatosis. Parkinsonism Relat Disord. 2019;58:12–6.CrossRefGoogle ScholarPubMed
Van Hove, J, Coughlin, C, II, Scharer, G. Glycine encephalopathy. GeneReviews®. 2002;Nov 14 (updated Jul 11, 2013).Google Scholar
Wang, D, Pascual, JM, De Vivo, D. Transporter type 1 deficiency syndrome. GeneReviews®. 2002;Jul 30 (updated Mar 1, 2018 ).Google Scholar
Toelle, SP, Wille, D, Schmitt, B, et al. Sensory stimulus-sensitive drop attacks and basal ganglia calcification: New findings in a patient with FOLR1 deficiency. Epileptic Disord. 2014;16(1):88–92.Google Scholar
Mastrangelo, M. Actual insights into treatable inborn errors of metabolism causing epilepsy. J Pediatr Neurosci. 2018;13(1):13–23.Google Scholar
Desai, S, Ganesan, K, Hegde, A. Biotinidase deficiency: A reversible metabolic encephalopathy. Neuroimaging and MR spectroscopic findings in a series of four patients. Pediatr Radiol. 2008;38(8):848–56.CrossRefGoogle Scholar
Bahi-Buisson, N, Kaminska, A, Nabbout, R, et al. Epilepsy in Menkes disease: Analysis of clinical stages. Epilepsia. 2006;47(2):380–6.CrossRefGoogle ScholarPubMed
Demarquay, G, Setiey, A, Morel, Y, et al. Clinical report of three patients with hereditary hemochromatosis and movement disorders. Mov Disord. 2000;15(6):1204–9.Google Scholar
Veerapandiyan, A, Winchester, SA, Gallentine, WB, et al. Electroencephalographic and seizure manifestations of pyridoxal 5’-phosphate-dependent epilepsy. Epilepsy Behav. 2011;20(3):494–501.CrossRefGoogle ScholarPubMed
Brautigam, C, Hyland, K, Wevers, R, et al. Clinical and laboratory findings in twins with neonatal epileptic encephalopathy mimicking aromatic L-amino acid decarboxylase deficiency. Neuropediatrics. 2002;33(3):113–7.Google Scholar
Stamelou, M, Mencacci, NE, Cordivari, C, et al. Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency. Neurology. 2012;79(5):435–41.CrossRefGoogle ScholarPubMed
Mancuso, M, Orsucci, D, Angelini, C, et al. Myoclonus in mitochondrial disorders. Mov Disord. 2014;29(6):722–8.Google Scholar
Cohen, BH, Chinnery, PF, Copeland, WC. POLG-related disorders. GeneReviews®. 2010;Mar 16 (updated Mar 1, 2018).Google Scholar
Salviati, L, Trevisson, E, Doimo, M, Navas, P. Primary coenzyme Q10 deficiency. GeneReviews®. 2017;Jan 26.Google Scholar
Walker, MA, Mohler, KP, Hopkins, KW, et al. Novel compound heterozygous mutations expand the recognized phenotypes of FARS2-linked disease. J Child Neurol. 2016;31(9):1127–37.CrossRefGoogle ScholarPubMed
Coughlin, CR, 2nd, Scharer, GH, Friederich, MW, et al. Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder. J Med Genet. 2015;52(8):532–40.CrossRefGoogle ScholarPubMed
Schultz, A, Ajavi, T, Specchio, N, et al. Study of intraventricular cerliponase alfa for CLN2 disease. N Engl J Med. 2018;378:1898–907.Google Scholar
Kim, J, Hu, C, Moufawad El Achkar, C, et al. Patient-customized oligonucleotide therapy for a rare genetic disease. N Engl J Med. 2019;381:1644–52.CrossRefGoogle ScholarPubMed
Monbaliu, E, De Cock, P, Mailleux, L, Dan, B, Feys, H. The relationship of dystonia and choreoathetosis with activity, participation and quality of life in children and youth with dyskinetic cerebral palsy. Eur J Paediatr Neurol. 2017;21(2):327–35.Google Scholar
Eggink, H, Kuiper, A, Peall, KJ, et al. Rare inborn errors of metabolism with movement disorders: A case study to evaluate the impact upon quality of life and adaptive functioning. Orphanet J Rare Dis. 2014;9:177.CrossRefGoogle ScholarPubMed
Dijk, JM, Tijssen, MA. Management of patients with myoclonus: Available therapies and the need for an evidence-based approach. Lancet Neurol. 2010;9(10):1028–36.Google Scholar